Fareston (KYOWA KIRIN, INC,)


Welcome to the PulseAid listing for the Fareston drug offered from KYOWA KIRIN, INC,. This Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: KYOWA KIRIN, INC,
NON-PROPRIETARY NAME: toremifene citrate
SUBSTANCE NAME: TOREMIFENE CITRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1997-06-30
END MARKETING DATE: 0000-00-00


Fareston HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFareston from KYOWA KIRIN, INC,
LABELER NAME: KYOWA KIRIN, INC,
DEA SCHEDULE:
ACTIVE STRENGTH: 60(mg/1)
START MARKETING DATE: 1997-06-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42747-327_2009e5ef-6524-4b62-b34f-145e63c371c4
PRODUCT NDC: 42747-327
APPLICATION NUMBER: NDA020497

Other TOREMIFENE CITRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
KYOWA KIRIN, INC,Fareston